A new study by Lyle Hood, assistant professor of mechanical engineering at The University of Texas at San Antonio (UTSA), describes a new device that could revolutionize the delivery of medicine to treat cancer as well as a host of other diseases and ailments.
Hood developed the device in partnership with Alessandro Grattoni, chair of the Department of Nanomedicine at Houston Methodist Research Institute.
“The problem with most drug-delivery systems is that you have a specific minimum dosage of medicine that you need to take for it to be effective,” Hood said. “There’s also a limit to how much of the drug can be present in your system so that it doesn’t make you sick.”
As a result of these limitations, a person who needs frequent doses of a specific medicine is required to take a pill every day or visit a doctor for injections. Hood’s creation negates the need for either of these approaches, because it’s a tiny implantable drug delivery system.
“It’s an implantable capsule, filled with medicinal fluid that uses about 5000 nanochannels to regulate the rate of release of the medicine,” Hood said. “This way, we have the proper amount of drugs in a person’s system to be effective, but not so much that they’ll harm that person.”
The capsule can deliver medicinal doses for several days or a few weeks. According to Hood, it can be used for any kind of ailment that needs a localized delivery over several days or a few weeks. This makes it especially tailored for treating cancer, while a larger version of the device, which was originally created by Grattoni, can treat diseases like HIV for up to a year.
“In HIV treatment, you can bombard the virus with drugs to the point that that person is no longer infectious and shows no symptoms,” Hood said. “The danger is that if that person stops taking their drugs, the amount of medicine in his or her system drops below the effective dose and the virus is able to become resistant to the treatments.”
The capsule, however, could provide a constant delivery of the HIV-battling drugs to prevent such an outcome. Hood noted it can also be used to deliver cortisone to damaged joints to avoid painful, frequent injections, and possibly even to pursue immunotherapy treatments for cancer patients.
“The idea behind immunotherapy is to deliver a cocktail of immune drugs to call attention to the cancer in a person’s body, so the immune system will be inspired to get rid of the cancer itself,” he said.
The current prototype of the device is permanent and injected under the skin, but Hood is working with Teja Guda, assistant professor of biomedical engineering, to collaborate on 3-D printing technology to make a new, fully biodegradable iteration of the device that could potentially be swallowed.
Learn more:Â UTSA study describes new minimally invasive device to treat cancer and other illnesses
[osd_subscribe categories=’drug-delivery-capsule’ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “DRUG DELIVERY CAPSULE”‘]
Receive an email update when we add a new DRUG DELIVERY CAPSULEÂ article.
The Latest on: Drug-delivery capsule
[google_news title=”” keyword=”drug-delivery capsule” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Drug-delivery capsule
- Lexaria Bioscience ethics review board approval to begin new GLP-1 studyon April 18, 2024 at 5:31 am
Lexaria Bioscience ethics review board approval to begin new GLP-1 study: Kelowna, BC Thursday, April 18, 2024, 18:00 Hrs [IST] Lexaria Bioscience Corp., a global innovator in dru ...
- Lexaria gets ethics board okay for oral GLP-1 studyon April 16, 2024 at 9:38 am
Lexaria Bioscience (NASDAQ:LEXX) said a third-party ethics review board has approved a human pilot study evaluating GLP-1 drugs formulated with its DehydraTECH drug delivery technology. The study will ...
- Gastroretentive Drug Delivery Systems Outsourcing Market [2028]: Dissecting Size, Share, and Competitive Intelligence - A TechSci Research Reporton April 11, 2024 at 2:23 am
The Global Gastroretentive Drug Delivery Systems Outsourcing Market, as revealed by the TechSci Research report titled “Gastroretentive Drug Delivery Systems Outsourcing Market – Global Industry Size, ...
- This multifunctional system can send drugs where they can be effective in body’s tissues, organson April 10, 2024 at 5:18 am
Drug delivery is a broad field of research that involves the development of new carrier systems and materials for effective therapeutic conveyance.
- Eli Lilly developing capsule device for drug delivery through GI wallon April 9, 2024 at 5:00 pm
Eli Lilly and Co. continues its development of an oral drug delivery device that can successfully deliver a drug that would otherwise be ineffective when taken orally.
- Biora Therapeutics Announces New Patent Covering its BioJet™ Liquid Jet Delivery Technologyon April 8, 2024 at 5:42 am
About Biora Therapeutics Biora Therapeutics is reimagining therapeutic delivery. By creating innovative smart pills designed for targeted drug delivery to the GI tract, and systemic, needle-free ...
- Nanocapsules: Tiny Vessels for Targeted Drug Delivery and Beyondon April 7, 2024 at 9:44 pm
These tiny capsules typically range in size from 10 to 1000 nanometers ... and tunable release profiles. They are widely used in drug delivery and biomedical applications. Lipid nanocapsules are ...
- Zanaflex Capsuleson November 26, 2021 at 10:56 pm
May sprinkle contents of capsules on applesauce (may affect absorption ... Avoid abrupt cessation. Elderly. Labor & delivery. Pregnancy. Nursing mothers. Avoid other α 2-agonists (eg, clonidine).
- Building a smart drug delivery technology for the esophaguson June 2, 2021 at 2:06 pm
The main feature of the EsoCap delivery system is a small capsule containing a coiled mucoadhesive film loaded with the drug. The capsule also contains a weight and a soluble thin thread.
via Bing News